Meeder Asset Management’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-2,383
| Closed | -$43K | – | 1104 |
|
2021
Q3 | $43K | Buy |
+2,383
| New | +$43K | ﹤0.01% | 1135 |
|
2020
Q2 | – | Sell |
-791
| Closed | – | – | 2012 |
|
2020
Q1 | $0 | Sell |
791
-425
| -35% | – | ﹤0.01% | 2301 |
|
2019
Q4 | $2K | Sell |
1,216
-3,379
| -74% | -$5.56K | ﹤0.01% | 1984 |
|
2019
Q3 | $5K | Buy |
4,595
+3,947
| +609% | +$4.3K | ﹤0.01% | 1743 |
|
2019
Q2 | $1K | Sell |
648
-1,015
| -61% | -$1.57K | ﹤0.01% | 1925 |
|
2019
Q1 | $10K | Buy |
1,663
+483
| +41% | +$2.9K | ﹤0.01% | 1232 |
|
2018
Q4 | $9K | Buy |
+1,180
| New | +$9K | ﹤0.01% | 1268 |
|
2017
Q2 | – | Sell |
-72
| Closed | -$2K | – | 1635 |
|
2017
Q1 | $2K | Buy |
+72
| New | +$2K | ﹤0.01% | 1339 |
|